NCN Grant for Cancer Immunotherapy

🚨 On 04.12.24 I’ve received my first NCN grant for our project “Innovative Small Molecule Inhibitors Targeting LAG-3 and MHCII Complex for Tumour Immunotherapy” 🎯Funded in the NZ7 panel, with nearly 3M PLN!Huge thanks to my collaborators!

NCN Funding in Immunotherapy

🚀 Another success! I received a SONATA grant in 2025 from NCN for our new project:“New Horizons in Cancer Immunotherapy: Blocking LAG-3/FGL1 Interactions” — this time focusing on FGL1, the second LAG-3 ligand.Funding: 2M PLNExcited for what’s ahead! #LAG3 #DrugDiscovery